FIELD: chemistry.
SUBSTANCE: invention relates to organic chemistry, specifically to novel imidazole derivatives of formula given below or pharmaceutically acceptable salt thereof, where Y denotes CH or N; R1 is: -alkyl containing 1-2 carbon atoms; - substituted alkyl containing 1-3 carbon atoms, which includes 1-3 substitutes, selected from a heteroaryl (selected from pyridine, thiazole furan), phenyl, halogen, wherein said heteroaryl and phenyl are substituted with 1-3 substitutes, selected from halogen, -OQ10, methylsulphonyl group, fluorophenox group and Q15; wherein Q10 is an alkyl containing 1-3 carbon atoms, and Q15 is hydrogen, alkyl containing 1-2 carbon atoms, which can be substituted with three halogen atoms; - cycloalkyl containing 3-6 carbon atoms; - amide (-CONH2) or alkyne containing 2-4 carbon atoms; -halogen; -phenyl; -substituted phenyl, containing 1-2 substitutes, selected from trifluoromethylphenoxy group, -OQ10, halogen, thiomorpholine; wherein Q10 is an alkyl, containing one carbon atom; -benzotriazole; R2 is: -alkyl, containing one carbon atom; -substituted alkyl, containing one carbon atom, containing 1-3 substitutes, selected from halogen and phenyl; -phenyl; R3 is -COW, where W is OR1, NHR1 or NR1R2. Invention also relates to a pharmaceutical composition based on a condensed imidazole derivative and use of said compound.
EFFECT: technical result is obtaining novel condensed imidazole derivatives, useful in treatment or prevention of tuberculosis.
19 cl, 4 dwg, 5 tbl
Title | Year | Author | Number |
---|---|---|---|
5,5-HETEROAROMATIC ANTI-INFECTIOUS COMPOUNDS | 2013 |
|
RU2696278C2 |
INHIBITORS OF TYPE ErbB INHIBITORS | 2006 |
|
RU2592703C9 |
PARENTERAL INTRAVENOUS AND PERORAL INTRODUCTION OF OXAZOLIDINONES FOR TREATMENT OF INFECTIOUS FOOT LESIONS IN DIABETES | 2003 |
|
RU2354372C2 |
MACROCYCLIC TYROSINE KINASE INHIBITOR AND ITS USE | 2019 |
|
RU2798231C2 |
IMIDAZOPYRIDINE DERIVATIVES AS MODULATORS OF TNF ACTIVITY | 2014 |
|
RU2696275C1 |
SOME CHEMICAL STRUCTURES, COMPOSITIONS AND METHODS | 2009 |
|
RU2513636C2 |
TETRAHYDROIMIDAZOPYRIDINE DERIVATIVES AS MODULATORS OF TNF ACTIVITY | 2014 |
|
RU2697090C1 |
BENZYLAMINE-CONTAINING HETEROCYCLIC COMPOUNDS AND COMPOSITIONS EFFECTIVE AGAINST MYCOBACTERIAL INFECTIONS | 2016 |
|
RU2793931C2 |
INFECTION-PROOF MEDICAL DEVICES | 2003 |
|
RU2314831C2 |
CONDENSED TRICYCLIC IMIDAZOLE DERIVATIVES AS MODULATORS OF TNF ACTIVITY | 2014 |
|
RU2700004C1 |
Authors
Dates
2017-01-23—Published
2010-11-05—Filed